Redox-mediated optochemical plasmonic sensing of H2O2-equivalent reducing capacity in exhaled breath condensate
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2026.119093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Xiaotong Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, 800 Dong Chuan Road, Shanghai, 200240, PR China. Hauptthemen laut MEDLINE: Hydrogen Peroxide, Biosensing Techniques. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Shanghai Municipal Health Commission, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
Oxidative-stress-related diseases generate elevated levels of hydrogen peroxide (H2O2) and other redox-active species in exhaled breath condensate (EBC), offering a promising avenue for non-invasive disease assessment. Despite its diagnostic potential, clinical translation of EBC redox species detection has been constrained by bulky analyzers, labor-intensive operation, and limited sensitivity. By harnessing the redox potential, we present a Redox-mediated Optochemical Plasmonic Sensing (ROPS) system, an ultrasensitive platform that enables real-time, easy-to-use, point-of-care quantitative analysis of H2O2-equivalent reducing capacity in EBC. By coupling H2O2-triggered gold nanoparticle growth on a phase-modulated plasmonic sensor, the ROPS system based on the phase-modulated interferometry achieved a detection limit of 1.19 pM and a wide dynamic range across 4 orders of magnitude. Moreover, the ROPS system demonstrated excellent reusability, maintaining stable H2O2 sensing performance over 40 reuse cycles. To enable point-of-care applications, we further developed a handheld high-efficiency EBC sampler, which harvested exhaled condensate at 2.49 μL/s and enabled an EBC-ROPS sampling-to-biosensing workflow down to 15 min. Clinical evaluation using EBC samples from lung and esophageal cancer patients and matched controls confirmed reliable quantification of trace H2O2-equivalent Au(III)-reducing capacity in complex EBC matrices, highlighting the potential of the integrated ROPS platform as a practical tool for point-of-care and non-invasive oxidative stress-related disease assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, 800 Dong Chuan Road, Shanghai, 200240, PR China.
- Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200032, PR China.
- Institute of Medical Robotics, School of Biomedical Engineering, Shanghai Jiao Tong University, 800 Dong Chuan Road, Shanghai, 200240, PR China; Shanghai Key Laboratory of Flexible Medical Robotics, Tongren Hospital, In…
Förderung
- Shanghai Municipal Health Commission
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Jiang, X., Gu, W., Huang, P., Wang, D., He, F., Liang, Y., Xi, B., Liu, L., Li, Y., Wu, J., Zha, Y., & Qiu, G. (2026). Redox-mediated optochemical plasmonic sensing of H2O2-equivalent reducing capacity in exhaled breath condensate. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.119093
Vancouver
Jiang X, Gu W, Huang P, Wang D, He F, Liang Y, et al. Redox-mediated optochemical plasmonic sensing of H2O2-equivalent reducing capacity in exhaled breath condensate. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2026.119093
BibTeX
@article{Jiang2026,
author = {Jiang, Xiaotong and Gu, Wei and Huang, Pengxin and Wang, Danhua and He, Fei and Liang, Yirou and Xi, Bangchao and Liu, Linlin and Li, Yunbo and Wu, Jiayun and Zha, Yang and Qiu, Guangyu},
title = {Redox-mediated optochemical plasmonic sensing of H2O2-equivalent reducing capacity in exhaled breath condensate},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2026.119093}
}
EUVIMED